Cerebral Amyloid Imaging Using Florbetapir (AV-45)
NCT02813434
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Dementia
Cognition Disorders
Interventions
BIOLOGICAL:
florbetapir
Sponsor
Centre Hospitalier Universitaire, Amiens